Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.31 - $0.57 $49,995 - $91,927
161,277 New
161,277 $79,000
Q3 2023

Nov 14, 2023

BUY
$0.46 - $0.91 $37,943 - $75,061
82,485 Added 165.3%
132,386 $60,000
Q2 2023

Aug 14, 2023

SELL
$0.91 - $1.05 $177,213 - $204,477
-194,740 Reduced 79.6%
49,901 $45,000
Q1 2023

May 15, 2023

BUY
$0.87 - $1.36 $212,837 - $332,711
244,641 New
244,641 $254,000
Q2 2022

Aug 15, 2022

SELL
$0.94 - $1.76 $39,835 - $74,585
-42,378 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$1.42 - $2.09 $34,413 - $50,651
-24,235 Reduced 36.38%
42,378 $63,000
Q3 2021

Nov 15, 2021

BUY
$1.42 - $2.0 $94,590 - $133,226
66,613 New
66,613 $111,000
Q1 2021

May 17, 2021

SELL
$1.31 - $3.0 $84,594 - $193,728
-64,576 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$0.96 - $1.51 $61,992 - $97,509
64,576 New
64,576 $87,000
Q2 2019

Aug 14, 2019

SELL
$0.79 - $1.66 $12,841 - $26,983
-16,255 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$0.73 - $2.1 $65,760 - $189,174
-90,083 Reduced 84.71%
16,255 $0
Q3 2018

Nov 13, 2018

BUY
$0.92 - $1.43 $65,752 - $102,202
71,470 Added 204.97%
106,338 $0
Q2 2018

Aug 10, 2018

BUY
$0.76 - $1.48 $26,499 - $51,604
34,868 New
34,868 $0
Q1 2018

May 11, 2018

SELL
$0.83 - $2.79 $9,362 - $31,471
-11,280 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$2.16 - $3.35 $24,364 - $37,788
11,280
11,280 $24,000

Others Institutions Holding DARE

About Dare Bioscience, Inc.


  • Ticker DARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,820,896
  • Market Cap $270M
  • Description
  • Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...
More about DARE
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.